Lisdexamfetamine 70 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DB25FAVZJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,027
Award facts
- Contract value 100% obligated
- $2,027.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,027.13 to DMS Pharmaceutical Group Inc. for Lisdexamfetamine 70 mg capsules (90-count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at DMS Pharmaceutical Group's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, which carries a potential value of $499,999,999 and remains valid through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply requirements of Department of Defense healthcare facilities worldwide. This positioning establishes DMS Pharmaceutical Group as a crucial vendor in fulfilling prescription medication needs across military health systems.
Quick answers
Who was awarded contract SPE2DB25FAVZJ?
SPE2DB25FAVZJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FAVZJ worth?
The government has obligated $2,027 on SPE2DB25FAVZJ.
Is contract SPE2DB25FAVZJ an order under another contract?
Yes. SPE2DB25FAVZJ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVZJ competed?
The extent of competition for SPE2DB25FAVZJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award